Investment Q&A

Q: I would just like to echo Francesco's email. Thank you.

Q: I had purchased CXR, aware of some inherent risk, but comforted to some degree by an element of reassurance from analysts I respect - including those at 5i - and held on to cxr, to my huge detriment having lost a significant amount of $ on Friday. This is not a question, but rather an expression of gratitude in the midst of CXR's debacle for the much-appreciated alert you provided us; I sold on Friday to redeploy the funds into something I hope will turn out to be more generous. Thanks again. It's time to move on. Regards.

Q: where can i find the article on cxr by modesto not long ago (april) on the potential of cxr. I think the article was in april or may.

Thx

Q: I know that you are removing from the Growth Portfolio today but what should an investor with real money on the line do that's down 70%. This was a 7% position in my portfolio. Should I just eat the loss and move on or hold for 5 years to see if I get my money back (or at least some of it)? I don't need access to the capital for at least another 15 years.

Q: Thanks a million for your email alert!! Time to say goodbye and I sold all of mine. Out here in Victoria we're slow to re-act because of the time difference. Thanks once again for EVERYTHING you do. Yes, the good ones will cover the losses.

Q: For those of us who bought CXR above 60$/share, selling here won't recover much cash and so I wonder, is there a point selling? What if like WIN or PHM, we sell near the bottom? The guidance is reduced, but some of this was out of their control (currency due to Brexit). If there was a fraud, yes, I agree, but EPS is 3.2% down and revenue revised by 18%. Not good, but they aren't the only ones with troubles (Brystol-Meyers and Gildan). At least they are doing something about it: laying off the CFO and cutting the (small) dividend.

Q: Trying to think of away to avoid two mistake made recently, or at least increase odds of avoiding in future.

PHM purchased and then up over 100% in few weeks/months, then down to minus 30%-50% range few weeks/months later.

CXR purchased and then up over 70% in few weeks, then down to minus 30%-50% range in a few more months.

Gross losses manageable as portfolio weighting was responsible.

PHM I guess fundamentals did not justify the increase and was popular stock at time is best thought I can think of and maybe a soft sell signal?

CXR seemed to go up on short covering, then down dramatically, then slightly back up on takeover rumours. No idea what to have done differently on this one. Feel like the CEO and CFO just dishonest on it.

Ideas? Lessons?

Q: ideas for replacement in healthcare on growth side? CAN ideally, US okay too

Q: Please your thoughts on the quarter, what were the estimates?

Thanks,
Dave

Q: Please comment on their results, dividend suspension & revised outlook

Q: 13.74 is pre market do i sell

Q: what are your thoughts on the earning release? would you still hold ?

Q: Is this the worst possible scenario for Concordia (CXR)...big writedown, suspended dividend, CFO resigns, lower guidance..etc. Does this constitute enough of a "change" to lead you to conclude that its time to move on?

Q: please give your opinion on cxr s quarterly report,thank you.

Q: I had asked on concordia with its results coming out shortly, whether the short position has been overdone and the company still has potential.

Q: I currently own Amaya and would like to sell and buy either CXR, KBL or PBH. How would you rank these 3 stocks for 2 year total return potential and why.

Q: What would be on your top 10 list for high conviction takeover targets in the next 6-12 months timeframe. You can exclude CXR,

Q: Peter and Team:
Above is a list of stocks I hold in an more aggressive non balanced account with no bias towards weighting. (I also hold a more balanced portfolio modelled much after yours--thank you!).

I am down 20-50% on all of these. I was wondering if you thought there were any I should cut loose now in search of better opportunities. I am patient (somewhat) with a long time horizon.

Thank you for a wonderful,ever improving service.

Phil

Q: I would like to increase my investment in the Canadian health care sector. I am looking for yield. What are your top recommendations? I already have enough Sienna (SIA) and Chartwell (CSH.UN). Pharmaceuticals and laboratories interest me.

Q: I am sure by now 5i must roll its collective eyes at the sight of another CXR question.
I don't own the stock but find it fascinating. Some analysts predict 2017 earnings to be $4-5 per share or even higher. Globeinvestor has their debt to equity at about 3x. My questions are these:
1. what is the major risk that the anticipated earnings don't materialize? gov't intervention? or is there fear that like Valiant there may be some misrepresentation on the books?

2. if debt to capital is 3x, that would mean that there is approx. $60 of debt per share, given a $20 share price. correct?

3. if they are paying an average of 5% interest on their debt, wouldn't interest alone eat most of their earnings? i.e. $3 per share would go just to interest. seems like it would take a very long time to get out of debt.

4. seems like it will be almost impossible for this company to grow by acquisition for a long time, given the environment. almost like a game of musical chairs where the music has stopped for a final time and there is no reason now to own the stock other than value. true?

Thanks for your patience with us as we try to figure this market out.

Cheers
John